Subscribe
Business

Abbott faces SEC and FTC investigation over infant formula operations

By Abigail Adcox
Published
Add Washington Examiner on Google
Abbott faces SEC and FTC investigation over infant formula operations

Abbott Laboratories is facing investigations from the Securities and Exchange Commission and Federal Trade Commission over its infant formula operation, marking the latest in a series of inquiries into the monthslong shutdown of a Michigan formula plant last year that kick-started a nationwide formula shortage.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Child Care Children FTC SEC Supply chain